V Kantorovich
Overview
Explore the profile of V Kantorovich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abreu M, Kantorovich V, Vasiliauskas E, Gruntmanis U, Matuk R, Daigle K, et al.
Gut
. 2004 Jul;
53(8):1129-36.
PMID: 15247180
Objectives: Many patients with Crohn's disease (CD) have low bone mineral density (BMD) that may not be solely attributable to glucocorticoid use. We hypothesised that low BMD in patients with...
2.
Kantorovich V, Gacad M, Seeger L, Adams J
J Clin Endocrinol Metab
. 2000 Nov;
85(10):3541-3.
PMID: 11061498
Two hundred and twenty-nine consecutive subjects, 202 women and 27 men, referred for evaluation of osteoporosis or low bone mineral density (BMD) had serum measurements of immunoreactive PTH (iPTH) and...
3.
Adams J, Kantorovich V, Wu C, Javanbakht M, Hollis B
J Clin Endocrinol Metab
. 1999 Aug;
84(8):2729-30.
PMID: 10443668
Vitamin D insufficiency is characterized biochemically by the presence of secondary hyperparathyroidism, which can contribute to bone loss in osteopenic patients. Over a 2-yr period of evaluation of 118 consecutive,...
4.
Adams J, Song C, Kantorovich V
Ann Intern Med
. 1999 Apr;
130(8):658-60.
PMID: 10215562
Background: Chronic hypercalciuria can contribute to osteoporosis, particularly in men. Objective: To ascertain the effects of resolution of hypercalciuria on bone mineral density. Design: Case series. Setting: Referral service for...
5.
Adams J, Kantorovich V
J Clin Endocrinol Metab
. 1999 Feb;
84(2):799-801.
PMID: 10022456
The 4-aminoquinolines, including chloroquine and hydroxychloroquine, have been successfully employed to treat patients with granuloma-forming disease-associated, vitamin D metabolite-mediated hypercalcemia. The calcium-lowering efficacy of these drugs has not been prospectively...